跳至主要内容
临床试验/IRCT2014100719427N1
IRCT2014100719427N1已完成2 期

Effects of intravenous and catheter directed thrombolytic therapy with recombinant tissue plasminogen activator (Alteplase) in non-traumatic acute limb ischemia; a randomized double-blind clinical trial

Vice chancellor of Research, Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Age 18 to 75 years; symptoms duration of 1 to 14 days; Acute limb ischemia (ALI) of grade IIa and IIb according to the Rutherford classification; absence of distal run off in angiography; Ankle-Brachial Index (ABI) less than 0.8
  • Exclusion criteria: Severe anemia (Hb less than 8 gr per dL); thrombocytopenia (platelet count less than 80000 per micl); low serum fibrinogen (fibrinogen less than 100 mg per dL); severe hypertension (systolic more than 160 mmHg, diastolic more than 100 mmHg); trauma or surgery less than 14 days before intervention; history of subarachnoid hemorrhage; life expectancy of less than 14 months; major internal bleeding less than 6 months before intervention; pregnancy; lumbar puncture 2 weeks before intervention

排除标准

  • 未提供

研究者

发起方
Vice chancellor of Research, Mashhad University of Medical Sciences

相似试验